Target intelligence / Profile preview

GIMAP1-GIMAP5 readthrough (GIMAP1-GIMAP5)

Target
GIMAP1-GIMAP5
Molecular classification
Other
01

Overview

The term "GIMAP1-GIMAP5 readthrough" refers to an mRNA transcript generated by transcriptional readthrough between the adjacent GIMAP1 (GTPase, IMAP family member 1) and GIMAP5 (GTPase, IMAP family member 5) genes. These genes encode small GTPases involved in immune cell signaling, but the readthrough product does not encode a recognized or functional protein. Its biological or therapeutic significance is not established, and it is not considered a therapeutic target or a validated gene product. The actual functional proteins, GIMAP1 and GIMAP5, are small GTPases with important roles in immune function and cell survival, particularly in T cells. However, the readthrough entity itself does not have an established role in any biological process, known disease, or drug interactions, and is likely included in databases primarily as a transcriptional annotation or artifact. If you are seeking information about the functional GIMAP1 or GIMAP5 proteins, those should be queried directly as they are well-characterized immune regulatory GTPases with distinct roles and molecular classification.

Other names
GIMAP1-GIMAP5 readthroughGIMAP1-GIMAP5 proteinGIMAP1-GIMAP5

Beyond the preview

Go deeper on GIMAP1-GIMAP5 readthrough (GIMAP1-GIMAP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GIMAP1-GIMAP5 readthrough (GIMAP1-GIMAP5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call